TERT PROMOTER MUTATIONS CORRELATE WITH A MORE ADVANCED STAGE AT DIAGNOSIS AND WITH A POORER PROGNOSIS IN DIFFERENTIATED THYROID CANCER
AIM OF THE STUDY:
A) To explore TERT promoter mutations in a large series of PTCs and FTCs and to correlate them with clinical and prognostic data; B) To investigate TERT expression and localization in neoplastic and normal thyroid tissues
RESULTS

CONCLUSIONS
•The PROGNOSTIC VALUE of telomerase mutations was shown in a large series of differentiated thyroid tumors
•Telomerase mutations were demonstrated to promote a HIGHER EXPRESSION and the EXCLUSION FROM THE NUCLEUS of the protein in neoplastic tissues, that might contribute to cancer progression through a mechanism independent from telomeres elongation Telomerase is a ribonucleoprotein polymerase that maintains telomere ends and plays a role in cellular senescence, being repressed in postnatal somatic cells.
Mutations C228T and C250T in promoter of telomerase reverse transcriptase (TERT) were recently reported in human cancers. 
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• the molecular pattern was IDENTICAL among the primary tumor and the lymph-node metastases in 5 cases
• The molecular pattern was DISCREPANT in 3 patients
This finding could be due to:  the selection of mutant alleles during tumor progression  or to the heterogeneous pattern of tumoral cells in the primary tumor with only some subclones able to metastatize Although the difference was not significant, TERT mutations were more frequent in BRAFV 600E than in BRAF WT cases
TERT mut 12%
TERT mut 14% Landa et al,2013; Vinagre et al, 2013; Liu T et al, 2013; Liu X et al, 2013; Melo et al, 2013; Liu X et al, 2014 In PTCs and FTCs, considered separately or pooled (PTCs + FTCs), TERT mutations were found to be significantly associated with an OLDER AGE AT DIAGNOSIS and a WORST OUTCOME
• Mean TERT/actin expression in TUMORS was significantly higher than in NORMAL TISSUES
• Moreover, TERT MUT tumors had a higher expression of the protein, though not at a significant level, with respect to TERT WT cases
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